Login to Your Account



UK Bioscience Gets $62M to Bridge Valley of Death

By Cormac Sheridan
Staff Writer

Tuesday, November 6, 2012
Twenty-two UK life sciences companies and a further 10 academic groups will share £39 million (US$62.3 million) in research funding in the largest grant allocation that the Biomedical Catalyst scheme has made to date.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription